By Memorandum Order entered by The Honorable Leonard P. Stark in Javelin Pharmaceuticals, Inc. et al. v. Mylan Laboratories Limited et al., Civil Action No. 16-224-LPS (D.Del., December 1, 2017), the Court denied without prejudice the motion to dismiss for improper venue or, in the alternative, to transfer venue to the Northern District of West Virginia of Defendant Mylan Laboratories Limited, Mylan, Inc. and Mylan Pharmaceutical Inc. (collectively, the “Mylan Defendants”). In doing so, the Court granted Plaintiffs’ request for venue-related discovery to proceed contemporaneously with the remainder of the case as it proceeds on the merits and ruled that the Mylan Defendants could renew the motion after a period of venue-related discovery. Id. at *1 and 12. The Court also held that Mylan’s venue challenge was not untimely and Mylan did not waive its challenge to venue by failing to press it until after the U.S. Supreme Court decided TC Heartland LLC v. Kraft Foods Grp. Brands LLC, 137 S. Ct. 1514 (2017) because the venue objection was not available until after that decision was rendered. Id. at *2.

A copy of the Memorandum Order is attached.